Literature DB >> 25323282

Sialidosis type I: ophthalmological findings.

Isa Sobral1, Maria da Luz Cachulo1, João Figueira1, Rufino Silva1.   

Abstract

Sialidosis is a lysosomal storage disease caused by deficit of neuraminidase. It is an autosomal recessive disease, heterogeneous in its onset, presentation and prognosis. We report a case of a male patient with molecular and enzymatic confirmation of the diagnosis. Symptoms began at age 26 with reduced visual acuity, bilateral cherry-red spots and later myoclonus. A brother, now deceased, had the same confirmed disease. We describe the symptoms and clinical findings of the patient, as well review the current knowledge on the topic. With this report, we highlight the importance of a clinical history integrating all the patient's symptoms in order to achieve the diagnosis. In the presence of a cherry-red spot, a comprehensive study is mandatory. Despite being a rare disease, sialidosis carries a significant burden for its patients and its diagnosis should always be considered in the appropriate setting. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2014        PMID: 25323282      PMCID: PMC4202095          DOI: 10.1136/bcr-2014-205871

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  14 in total

1.  Observations on time course changes of the cherry red spot in a patient with Tay-Sachs disease.

Authors:  M Nakaya-Onishi; A Suzuki; N Okamoto; M Fukada
Journal:  Br J Ophthalmol       Date:  2000-11       Impact factor: 4.638

2.  "Cherry-red spot" or "perifoveal white patch"?

Authors:  Luis H Ospina; Christopher J Lyons; Andrew Q McCormick
Journal:  Can J Ophthalmol       Date:  2005-10       Impact factor: 1.882

3.  First report of two Taiwanese siblings with sialidosis type I: a 10-year follow-up study.

Authors:  Chiung-Mei Chen; Szu-Chia Lai; I-Cheng Chen; Kai-Cheng Hsu; Rong-Kuo Lyu; Long-Sun Ro; Hong-Shiu Chang
Journal:  J Neurol Sci       Date:  2006-05-18       Impact factor: 3.181

4.  The "cherry red" spot.

Authors:  Jacqueline A Leavitt; Suresh Kotagal
Journal:  Pediatr Neurol       Date:  2007-07       Impact factor: 3.372

Review 5.  Type II sialidosis: review of the clinical spectrum and identification of a new splicing defect with chitotriosidase assessment in two patients.

Authors:  A Caciotti; M Di Rocco; M Filocamo; S Grossi; F Traverso; A d'Azzo; C Cavicchi; A Messeri; R Guerrini; E Zammarchi; M A Donati; Amelia Morrone
Journal:  J Neurol       Date:  2009-07-01       Impact factor: 4.849

Review 6.  Lysosomal multienzyme complex: pros and cons of working together.

Authors:  Erik J Bonten; Ida Annunziata; Alessandra d'Azzo
Journal:  Cell Mol Life Sci       Date:  2013-12-15       Impact factor: 9.261

7.  Clinical and serial MRI findings of a sialidosis type I patient with a novel missense mutation in the NEU1 gene.

Authors:  Yoshiki Sekijima; Katsuya Nakamura; Dai Kishida; Aya Narita; Kaori Adachi; Kosaku Ohno; Eiji Nanba; Shu-Ichi Ikeda
Journal:  Intern Med       Date:  2013-01-01       Impact factor: 1.271

8.  Lysosomal multienzymatic complex-related diseases: a genetic study among Portuguese patients.

Authors:  M F Coutinho; L Lacerda; S Macedo-Ribeiro; E Baptista; H Ribeiro; M J Prata; S Alves
Journal:  Clin Genet       Date:  2011-03-01       Impact factor: 4.438

9.  Variable phenotype and severity of sialidosis expressed in two siblings presenting with ataxia and macular cherry-red spots.

Authors:  Wladimir Bocca Vieira de Rezende Pinto; Paulo Victor Sgobbi de Souza; José Luiz Pedroso; Orlando G P Barsottini
Journal:  J Clin Neurosci       Date:  2013-07-16       Impact factor: 1.961

10.  Sialidosis type I carrying V217M/G243R mutations in lysosomal sialidase: an autopsy study demonstrating terminal sialic acid in lysosomal lamellar inclusions and cerebellar dysplasia.

Authors:  Toshiki Uchihara; Ken-ichi Ohashi; Masanobu Kitagawa; Morito Kurata; Ayako Nakamura; Katsuiku Hirokawa; Tsutomu Kasuga; Takayoshi Kobayashi
Journal:  Acta Neuropathol       Date:  2009-05-05       Impact factor: 17.088

View more
  8 in total

Review 1.  NEU1-A Unique Therapeutic Target for Alzheimer's Disease.

Authors:  Aiza Khan; Consolato M Sergi
Journal:  Front Pharmacol       Date:  2022-06-29       Impact factor: 5.988

2.  Genetic and clinical characterization of mainland Chinese patients with sialidosis type 1.

Authors:  Xiaoxu Han; Shijing Wu; Min Wang; Hui Li; Yan Huang; Ruifang Sui
Journal:  Mol Genet Genomic Med       Date:  2020-05-26       Impact factor: 2.183

3.  Compound heterozygous mutations in the neuraminidase 1 gene in type 1 sialidosis: A case report and review of literature.

Authors:  Lan-Xiao Cao; Ying Liu; Zhao-Jun Song; Bao-Rong Zhang; Wen-Ying Long; Guo-Hua Zhao
Journal:  World J Clin Cases       Date:  2021-01-26       Impact factor: 1.337

4.  Anesthetic management for mastectomy and total hysterectomy in a 49-year-old woman with type 1 sialidosis: a case report.

Authors:  Tomonori Furuya; Masumi Itagaki; Nami Sugaya; Ryoji Iida; Takeshi Maeda; Takahiro Suzuki
Journal:  JA Clin Rep       Date:  2021-03-04

5.  Looking "Cherry Red Spot Myoclonus" in the Eyes: Clinical Phenotype, Treatment Response, and Eye Movements in Sialidosis Type 1.

Authors:  Giulietta M Riboldi; John Martone; John-Ross Rizzo; Todd E Hudson; Janet C Rucker; Steven J Frucht
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2021-12-09

6.  Pathogenesis, Emerging therapeutic targets and Treatment in Sialidosis.

Authors:  Alessandra d'Azzo; Eda Machado; Ida Annunziata
Journal:  Expert Opin Orphan Drugs       Date:  2015-04-13       Impact factor: 0.694

7.  Bergmeister's papilla in a young patient with type 1 sialidosis: case report.

Authors:  Settimio Rossi; Carlo Gesualdo; Antonio Tartaglione; Leonilda Bilo; Antonietta Coppola; Francesca Simonelli
Journal:  BMC Ophthalmol       Date:  2020-08-31       Impact factor: 2.209

Review 8.  Sialidosis: A Review of Morphology and Molecular Biology of a Rare Pediatric Disorder.

Authors:  Aiza Khan; Consolato Sergi
Journal:  Diagnostics (Basel)       Date:  2018-04-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.